Status:
UNKNOWN
The Rhytmia System to Determine the Precise Location and Potential Mechanism of Premature Contractions
Lead Sponsor:
University Hospital, Toulouse
Collaborating Sponsors:
Boston Scientific Group
Conditions:
Cardiac Arrhythmia
Cardiomyopathy, Dilated
Eligibility:
All Genders
18+ years
Brief Summary
This is a purely observational project and the objectives are to record and analyze the local potentials at the site of Premature Ventricular Contraction (VPC) focus through the Rhythmia system, ti de...
Detailed Description
This is a purely observational study. No special methodology choice, no comparison. The study want to find the determination of precise location of the focus and mechanisms involved constitutes a cha...
Eligibility Criteria
Inclusion
- patients with symptomatic monomorphic PVC with or without heart disease refractory to anti arrhythmic drugs
- patients with dilated cardiomyopathy and altered Left Ventricular Ejection Fraction (LVEF) suspected to be causes by frequent monomorphic VPC
- patients with malignant ventricular arrhythmias reproducibly induced by monomorphic PVC
Exclusion
- patients with non-symptomatic VPC and without cardiomyopathy
- patients under 18 yo
- pregnant women
- patients with polymorphic PVC arising from clearly different areas
- patient protected by the french law: guardianship and Trusteeship
Key Trial Info
Start Date :
June 14 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03460535
Start Date
June 14 2017
End Date
June 1 2019
Last Update
March 9 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Toulouse
Toulouse, France, 31059